PhaseBio Pharmaceuticals' Convertible Note Round

PhaseBio Pharmaceuticals raised a round of funding on January 31, 2017.

PhaseBio Pharmaceuticals is a clinical-stage biopharmaceutical company developing drugs to treat diabetes and cardiovascular dysfunction in patients suffering from rare diseases. The Company's discove…

Articles about PhaseBio Pharmaceuticals' Convertible Note Round: